日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer

基于结构的设计用于治疗癌症的 CDC42 效应相互作用抑制剂

Sohail Jahid, Jose A Ortega, Linh M Vuong, Isabella Maria Acquistapace, Stephanie J Hachey, Jessica L Flesher, Maria Antonietta La Serra, Nicoletta Brindani, Giuseppina La Sala, Jacopo Manigrasso, Jose M Arencibia, Sine Mandrup Bertozzi, Maria Summa, Rosalia Bertorelli, Andrea Armirotti, Rongsheng J

Design, Synthesis, Dynamic Docking, Biochemical Characterization, and in Vivo Pharmacokinetics Studies of Novel Topoisomerase II Poisons with Promising Antiproliferative Activity

具有良好抗增殖活性的新型拓扑异构酶 II 毒物的设计、合成、动态对接、生化表征及体内药代动力学研究

Jose M Arencibia, Nicoletta Brindani, Sebastian Franco-Ulloa, Michela Nigro, Jissy Akkarapattiakal Kuriappan, Giuliana Ottonello, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Marco De Vivo

Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β

新型、有效且类似药物的四氢喹唑啉抑制剂,对人类拓扑异构酶 II α 比 β 具有更高的选择性

Jose Antonio Ortega, Jose M Arencibia, Elirosa Minniti, Jo Ann W Byl, Sebastian Franco-Ulloa, Marco Borgogno, Vito Genna, Maria Summa, Sine Mandrup Bertozzi, Rosalia Bertorelli, Andrea Armirotti, Anna Minarini, Claudia Sissi, Neil Osheroff, Marco De Vivo